Sandu Pharmaceuticals reports standalone net profit of Rs 0.38 crore in the December 2017 quarter

Sales rise 49.64% to Rs 16.70 crore

Net profit of Sandu Pharmaceuticals remain constant at Rs 0.38 crore in the quarter ended December 2017 and also during the previous quarter ended December 2016. Sales rose 49.64% to Rs 16.70 crore in the quarter ended December 2017 as against Rs 11.16 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales16.7011.16 50 OPM %5.757.62 -PBDT0.670.89 -25 PBT0.540.71 -24 NP0.380.38 0

Powered by Capital Market - Live News